Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Hayes

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Blood|September 27, 2003
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology GroupJacob M Rowe, Donna Neuberg, William Friedenberg, et al.
Transplantation and Cellular Therapy|September 5, 2025
The Clinical Utility of Real-Time Patient Reported Outcomes in Cell Therapy RecipientsKenneth R Meehan, Julie Doherty, Joel King, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2025
Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot StudyArvind Suresh, Heather A Wishart, Maeen N Arslan, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Blood|September 27, 2003
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology GroupJacob M Rowe, Donna Neuberg, William Friedenberg, et al.
Transplantation and Cellular Therapy|September 5, 2025
The Clinical Utility of Real-Time Patient Reported Outcomes in Cell Therapy RecipientsKenneth R Meehan, Julie Doherty, Joel King, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2025
Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot StudyArvind Suresh, Heather A Wishart, Maeen N Arslan, et al.
Pageof 3